Statins and their use in preventing carotid disease.
Carotid disease may be evaluated by surrogate outcomes, such as intima-media thickness and carotid plaque features, and by clinical end points. Statins stop progression or may induce regression of intima-media thickness, and statins may also stop plaque growth or even induce reduction of plaque volume. Areas rich in lipids within plaques may be reduced in size and/or in number of inflammatory cells. Ultrasound reflectivity may be reduced by statin treatment, indicating less lipid/inflammatory content. Finally, statins appear to reduce the risk of all cardiovascular events (eg, stroke, myocardial infarction, need for revascularization) in patients with carotid stenosis. This review summarizes and discusses the existing data.
Sillesen
Henrik
H
Department of Vascular Surgery, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK 2100, Denmark. sillesen@mac.com
D016893:Carotid Stenosis / Q000209:etiology / Q000473:pathology* / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors